Navigation Links
Halozyme Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/5/2010

SAN DIEGO, Nov. 5, 2010 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the third quarter ended September 30, 2010.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100302/LA63139LOGO)

"Halozyme achieved further clinical advances during the third quarter as we began additional studies for our Ultrafast Insulin and PEGPH20 proprietary programs," said Jonathan Lim, M.D., Halozyme's president and CEO. "In addition, we are excited by the continuing progress of our partners as Baxter and Roche presented positive data at medical meetings from their clinical trials for subcutaneous immunoglobulin and Herceptin SC, products that utilize our core rHuPH20 enzyme technology."

Third Quarter 2010 and Recent Business Highlights

  • Halozyme began patient dosing for two Phase 2 Ultrafast Insulin treatment studies that utilize rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®. Diabetes patients enrolled in these trials will receive an insulin analog alone and the Analog-PH20 treatment for 12 weeks each.
    '/>"/>

    • SOURCE Halozyme Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    2. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
    3. Halozyme Therapeutics to Present at Upcoming Investor Conferences
    4. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
    5. Halozyme Therapeutics to Host Research Day for Investors and Analysts
    6. Halozyme Therapeutics to Present at Upcoming Investor Conferences
    7. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
    8. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
    9. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
    10. Halozyme Receives $5.5 Million Payment From Baxter
    11. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
    (Date:5/21/2013)... 2013  Personal Genome Diagnostics Inc. (PGDx), today ... and expertise in genomic analysis of defined cancer ... with Blueprint Medicines.  PGDx is an innovator in ... in tumors, and Blueprint Medicines is an expert ... genetically defined patient population. "This collaboration ...
    (Date:5/21/2013)... Vital Imaging ™ has teamed ... San Diego for a joint study which aims to ... Resonance Imaging) with that of a supine Dynawell MRI ... of improved healthcare by combining cutting edge technology with ... valuable tool for evaluating pathological changes in the spine, ...
    (Date:5/21/2013)... Clinovo's new “CDISC Standards: Theory ... starting on June 11th, 2013. The TechTrainings are technical ... the next step in their professional career. The class ... and streamed online. , Taught by Sy Truong, President ... “CDISC Standards: Theory and Application” class will give an ...
    Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3Clinovo Launches TechTrainings on CDISC Standards 2
    ... of researchers led by the University of Colorado at ... measles prevention and slated for human clinical trials later ... inexpensive vaccines for illnesses ranging from tuberculosis to cervical ... a team led by CU-Boulder chemistry and biochemistry Professor ...
    ... water purification, faster computers, tougher shoe soles, and lighter ... Queensland University of Technology (QUT) scientist has discovered a ... Adrian Fuchs, from QUT,s School of Physical and Chemical ... model for dispersing metals in nanoparticle form throughout polymers ...
    ... 5 Hendrick Construction, Inc. finished a 14,000-square-foot expansion ... the world,s premier research facilities. , ... The Tennessee project created 13 new labs to ... most powerful pulsed source of neutrons for the study of materials. Scientific ...
    Cached Biology Technology:New inhalable measles vaccine may lead to vaccines for other diseases 2New inhalable measles vaccine may lead to vaccines for other diseases 3New inhalable measles vaccine may lead to vaccines for other diseases 4Hendrick Construction Completes Oak Ridge National Laboratory Expansion 2
    (Date:5/17/2013)... white noise of the South, but the night belongs to ... hangs heavy from the humidity and the sounds of wildlife. ... of frogs, toads and salamanders, is the center of amphibian ... are the auditorium for their symphonic choruses, the scientists of ... ARMI, have front-row seats. , Amphibians, which rely ...
    (Date:5/17/2013)... China---- Why Tibetan antelope can live at elevations ... collaborative research published in Nature Communications , ... provide evidence that some genetic factors may be ... environments. The data in this work will also ... the biology of other ruminant species. , The ...
    (Date:5/17/2013)... international team of scientists using a new X-ray method ... living frog embryo in greater detail than ever before., ... research and the search for new treatments for genetic ... fr Technologie in Germany, in collaboration with the Advanced ... National Laboratory, released the most precise depiction ever of ...
    Breaking Biology News(10 mins):Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2New X-ray method shows how frog embryos could help thwart disease 2
    ... the world,s rarest gorilla have good news: the Cross ... including vital corridors that, if protected, can help the ... according to the North Carolina Zoo, the Wildlife Conservation ... published habitat analysis, which used a combination of satellite ...
    ... January 31 People who have Ulcerative Colitis (UC) ... for extending their time between flares is crucial to ... a personalized combination of drugs, dietary changes and, for ... designated for the dietary management of these conditions. Now, ...
    ... release is available in German . , ... very clear message with which Peter Hofer, a member of ... Briefing on scarce metals held at the Empa Academy. After ... keep electric vehicles rolling and which, in automobile catalytic converters, ...
    Cached Biology News:Satellite study reveals critical habitat and corridors for world's rarest gorilla 2Satellite study reveals critical habitat and corridors for world's rarest gorilla 3Maker of VSL#3 probiotic offers assistance program for ulcerative colitis and ileal pouch patients 2No future without scarce metals 2No future without scarce metals 3No future without scarce metals 4
    Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
    Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
    ... The Brownlee Precision Model 440 incorporates ... circuitry in a friendly easy-to-use instrument. Each ... amplifier, an 8-pole Bessel lowpass filter, a ... output offset controls. A control knob sets ...
    ... fully licensed, high throughput, water bath thermal cycler ... 24 microplates. This equates to 9,216 reactions per ... robotic arm rapidly transfers a basket of plates ... times that are considerably faster than those of ...
    Biology Products: